去甲肾上腺素在脓毒症中失调免疫反应并损害宿主防御
研究探讨去甲肾上腺素与替代性升压药血管加压素对免疫反应和宿主防御的影响:6至9名供者白细胞在去甲肾上腺素或血管加压素存在与否下刺激;190只C57BL/6J小鼠经微渗透泵持续输注去甲肾上腺素或血管加压素并接受LPS攻击或盲肠结扎穿孔;30名健康志愿者随机接受去甲肾上腺素、血管加压素或生理盐水5小时输注并静脉LPS攻击;另在195例脓毒症休克患者中评估去甲肾上腺素输注速率与β受体阻滞剂使用及血浆细胞因子的关系。结果显示去甲肾上腺素在体外与LPS攻击小鼠中减弱促炎介质和活性氧产生、增强抗炎IL-10产生;盲肠结扎穿孔时输注去甲肾上腺素使细菌向脾、肝和血液播散增加;LPS攻击志愿者中去甲肾上腺素提高血浆IL-10浓度并减弱促炎细胞因子IFN-γ诱导蛋白10释放;血管加压素在所有实验设置中无免疫调节作用。患者中较高的去甲肾上腺素输注速率与更偏抗炎的细胞因子平衡相关,而β受体阻滞剂使用与更偏促炎的细胞因子平衡相关。
要点
- 去甲肾上腺素在体外和LPS攻击小鼠中减弱促炎介质与活性氧产生、增强抗炎IL-10产生。
- 盲肠结扎穿孔小鼠持续输注去甲肾上腺素后,细菌向脾、肝和血液的播散增加。
- 30名健康志愿者LPS攻击后,去甲肾上腺素提高血浆IL-10并减弱IFN-γ诱导蛋白10释放。
- 血管加压素在体外、小鼠和人体实验设置中均未显示免疫调节作用。
- 195例脓毒症休克患者中,较高去甲肾上腺素输注速率与更偏抗炎的细胞因子平衡相关,β受体阻滞剂使用与更偏促炎的细胞因子平衡相关。
适用人群与场景
- 体外实验使用6至9名供者的白细胞。
- 动物实验使用190只C57BL/6J小鼠,接受LPS攻击或盲肠结扎穿孔。
- 人体实验为30名健康志愿者,随机接受5小时去甲肾上腺素、血管加压素或生理盐水输注并静脉LPS攻击。
- 临床观察为195例脓毒症休克患者。
处置流程与药物剂量
- 小鼠经微渗透泵持续输注去甲肾上腺素或血管加压素。
- 健康志愿者接受5小时去甲肾上腺素、血管加压素或生理盐水输注,并接受静脉LPS攻击。
研究设计与关键结果
- 研究类型包括体外白细胞刺激实验、小鼠实验、健康志愿者随机对照人体实验及脓毒症休克患者观察性分析。
- 体外与LPS攻击小鼠中,去甲肾上腺素减弱促炎介质和活性氧产生、增强抗炎IL-10产生。
- 盲肠结扎穿孔小鼠输注去甲肾上腺素后,细菌向脾、肝和血液播散增加。
- LPS攻击志愿者中去甲肾上腺素提高血浆IL-10浓度并减弱促炎细胞因子IFN-γ诱导蛋白10释放。
- 血管加压素在所有实验设置中均无免疫调节作用。
- 195例脓毒症休克患者中,较高去甲肾上腺素输注速率与更偏抗炎的细胞因子平衡相关,β受体阻滞剂使用与更偏促炎的细胞因子平衡相关。
证据类型、等级与局限
- 证据类型:体外实验、小鼠实验、健康志愿者随机对照人体实验及患者观察性分析。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为去甲肾上腺素可能显著促成脓毒症诱导的免疫麻痹,而血管加压素不具有不良免疫学效应。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Sepsis is characterized by a dysregulated immune response to infection. Norepinephrine, the cornerstone vasopressor used in septic shock, may contribute to immune dysregulation and impact host defense.Objectives: To investigate effects of norepinephrine and the alternative vasopressor vasopressin on the immune response and host defense.Methods: Leukocytes from six to nine donors were stimulated in the presence or absence of norepinephrine and vasopressin. A total of 190 C57BL/6J mice received a continuous infusion of norepinephrine or vasopressin via microosmotic pumps and were challenged with LPS or underwent cecal ligation and puncture. Thirty healthy volunteers were randomized to a 5-hour infusion of norepinephrine, vasopressin, or saline and intravenously challenged with LPS. The relationship between the norepinephrine infusion rate and the use of β-blockers and plasma cytokines was assessed in 195 patients with septic shock.Measurements and Main Results: Norepinephrine attenuated the production of proinflammatory mediators and reactive oxygen species and augmented antiinflammatory IL-10 production both in vitro and in LPS-challenged mice. Norepinephrine infusion during cecal ligation and puncture resulted in increased bacterial dissemination to the spleen, liver, and blood. In LPS-challenged volunteers, norepinephrine enhanced plasma IL-10 concentrations and attenuated the release of the proinflammatory cytokine IFN-γ-induced protein 10. Vasopressin exerted no immunomodulatory effects across these experimental setups. In patients, higher norepinephrine infusion rates were correlated with a more antiinflammatory cytokine balance, whereas β-blocker use was associated with a more proinflammatory cytokine balance.Conclusions: Norepinephrine dysregulates the immune response in mice and humans and compromises host defense. Therefore, it may significantly contribute to sepsis-induced immunoparalysis, whereas vasopressin does not have untoward immunologic effects.
参考来源
- Stolk RF, van der Pasch E, Naumann F, et al. Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis. Am J Respir Crit Care Med. 2020. PMID: 32520577. doi:10.1164/rccm.202002-0339OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。